drugset / Trial / NCT01217099

Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children

NCT01217099

Terminated 47 enrolled Chongqing Medical University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is planned to investigate whether small doses of methylprednisolone pulse macrolide therapy can relieve symptoms,chest X-rays faster than macrolide alone therapy for refractory mycoplasma pneumoniae pneumonia(MPP) .

Timeline

Start
2007-05
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified Intravenous
Comparator Azithromycin Small molecule Intravenous